We are monitoring the impact of COVID-19 & Recession alarm on Cancer Profiling Market Get in touch with us for detailed analysis Know More

Know More

Share on

Global Cancer Profiling Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Technology, Technique, Application & Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 8736
Pages: 250

Cancer Profiling Market Size (2022 to 2027)

The global cancer profiling market is estimated to be worth USD 21.26 Billion by 2027 from USD 10.26 billion in 2022, registering a CAGR of more than 15.68% % from 2022 to 2027.

Impact of COVID-19 on the global cancer profiling market:

The coronavirus outbreak has implemented strict regulations with minimizing contact and adhering to lockdown policies, thus impacting routine cancer screening.  During 2020- 2021, there was a notable decrease in cancer diagnosis as few symptoms were mistaken for COVID-19 infections like lung cancer or mild respiratory illness. Studies claim that cancer patients may be more vulnerable to COVID-19 than people without cancer. Factors such as a shortage of skilled professionals due to the displacement of medical workers and technical difficulties in sample collection and storage severely challenged the studied market during the pandemic. However, precision medicine has a potential growth opportunity that can help identify patients who may need cancer treatment with NGS or genomic biomarkers.

Increasing incidences of various cancer diseases and the rise in living standards are significant factors propelling the growth of the cancer profiling market.

The number of people affected with cancer is significantly boosting the market for cancer profiling. As per facts published by the American Cancer Society, an estimated 1.8 million new cancer cases were detected in 2018, and the incidence of cancer is projected to increase more in the coming future. Adopting a sedentary lifestyle and changes in food habits could lead to getting diagnosed with cancer.

Cancer tumor profiling evaluates the properties and metabolism of the cells and understands the molecular level while diagnosing. The growing prevalence of effective treatment procedures and the rise in the geriatric population further accelerate the growth of the cancer profiling market. Growth opportunities for the market lie in the increasing demand for targeted therapies where the patient has a prominent response to the therapy. Also, the growing prevalence of effective treatment procedures at any cost and the rise in the use of biomarkers for treating cancer are further anticipated to boost the growth rate of the cancer profiling market.

The cost of installing the equipment is very high and is predicted to restrict the growth rate of the cancer profiling market.

The lack of skilled physicians in making accurate decisions through reports is impeding the growth of the market. Also, the devices need regular inspection as there is a chance for failure in real-time applications where staff-members negligence in maintaining the devices is slowly restraining the growth of the cancer profiling market.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Technology, Technique, Application, Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

 

This market research report on the global cancer profiling market has been segmented and sub-segmented based on the technology, technique, application, and region.

Cancer Profiling Market - By Technology:

  • Next-generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • In Situ Hybridization (ISH)
    • Fluorescence In Situ Hybridization (FISH)
    • Chromogenic In Situ Hybridization (CISH)
  • Microarray
  • Others

Based on the technology, the NGS segment accounted for the largest share of the cancer profiling market in 2021, owing to factors such as a rise in the government's support and changing schemes in favor of the public.

Cancer Profiling Market - By Technique:

  • Genomics
  • Proteomics
  • Epigenetics
  • Metabolomics

Based on the technique, the genomics segment led the cancer profiling market in 2021. Increasing demand for personalized medicine and the rise in disposable income in urban areas are expected to favor the growth of this segment.

Cancer Profiling Market - By Application:

  • Personalized Medicine
  • Diagnostics
  • Biomarker Discovery
  • Prognostics
  • Research Applications

Based on the application, the personalized medicine segment registered the largest share of the global cancer profiling market in 2021 due to the rise in the scale of research institutes and the demand to promote human wellbeing after cancer therapies.

Cancer Profiling Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographically, North America accounted for a significant share of the global cancer profiling market in 2021, owing to the rise in capital income in developed and developing countries. Also, the availability of skilled persons to perform effective targeted surgeries for cancer broadens the market growth.

Regions such as Europe and the Asia Pacific are predicted to hold a substantial share of the global market during the forecast period due to the increasing elderly population and the government's launch of the reimbursement scheme concerning people’s health.

The cancer profiling market in the Middle East and Africa is projected to have inclined growth rates in the coming years with the rise in awareness of treatment procedures and the implementation of various techniques in diagnostics centers.

TOP COMPANIES IN THIS MARKET:

Some of the most promising companies in the global cancer profiling market profiled in this report are Illumina, Inc. (US), QIAGEN N.V. (Germany), NeoGenomics Laboratories, Inc. (U.S.), HTG Molecular Diagnostics, Inc. (U.S.), Genomic Health Inc. (U.S.), Caris Life Sciences (U.S.), Helomics Corporation (U.S.), NanoString Technologies, Inc. (U.S.), Sysmex Corporation (Japan), RiboMed Biotechnologies, Inc. (U.S.), Guardant Health, Inc. (U.S.), and Foundation Medicine (U.S.)

RECENT HAPPENINGS IN THIS MARKET:

  • HTG Molecular Technologies, Inc. has developed a product for tumor profiling called Edge Seq mouse mRNA tumor response panel. The significant applications of this product are analysis of immune response to xenografts, detailed investigational research of therapeutics, and oncogenesis modeling. This tumor response panel enables the profiling of various samples, such as extracted RNA samples, FFPE tissue, and cell lines.
  • In May 2019, Caris completed the deal to acquire Phamatech, Inc. With this company's acquisition, Caris has expanded its share by including an oncology network and other clinical trials for precision oncology.
  • In May 2019, QIAGEN NV Company developed a diagnostic kit called therascreen PIK3CA. The objective of this kit is to detect breast cancer in patients.
  • In February 2019, Sysmex Corporation expanded its business in the UK by inaugurating a new operations unit. The new facility in Cambridge will handle the operations of the company’s fish probe and Cytocell brands.
  • In May 2019, QIAGEN Company collaborated with other UK-originated organizations to launch APIS Assay Technologies Ltd.; the company's primary objective is to enhance the biomarker products and achieve a better success rate of biomarker commercialization.
  1. Introduction
    1. Market Definition                                    
    2. Study Deliverables                                  
    3. Base Currency, Base Year and Forecast Periods                                          
    4. General Study Assumptions                                
  2. Research Methodology
    1. Introduction                                               
    2. Analysis Design                                         
    3. Research Phases                                      
      1. Secondary Research                           
      2. Primary Research                 
      3. Econometric Modelling                      
      4. Expert Validation                  
    4. Study Timeline                                          
  3. Overview
    1. Executive Summary                                
    2. Key Inferences                                         
    3. New Developments                                               
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers                                          
    2. Market Restraints                                    
    3. Key Challenges                                         
    4. Current Opportunities in the Market                                              
  5. Market Segmentation
    1. Global Cancer/Tumor Profiling Market, By Technology
      1. Next-generation Sequencing (NGS)
      2. Polymerase Chain Reaction (PCR)
      3. Immunohistochemistry (IHC)
      4. In Situ Hybridization (ISH)
        1. Fluorescence In Situ Hybridization (FISH)
        2. Chromogenic In Situ Hybridization (CISH)
      5. Microarray
      6. Others
    2. Global Cancer/Tumor Profiling Market, By Technique
      1. Genomics
      2. Proteomics
      3. Epigenetics
      4. Metabolomics
    3. Global Cancer/Tumor Profiling Market, By Application
      1. Personalized Medicine
      2. Diagnostics
      3. Biomarker Discovery
      4. Prognostics
      5. Research Applications
  6. Geographical Analysis
    1. North America                                          
      1. Introduction                           
      2. United States                         
      3. Canada                     
    2. Europe                                         
      1. Introduction                           
      2. U.K                             
      3. Spain                         
      4. Germany                 
      5. Italy                            
      6. France                       
    3. Asia-Pacific                                 
      1. Introduction                           
      2. China                         
      3. India                          
      4. Japan                         
      5. South Korea                           
    4. Latin America                                             
      1. Introduction                           
      2. Brazil                          
      3. Argentina                
      4. Mexico                     
    5. Middle East & Africa 
      1. Introduction
      2. Middle-East
      3. Africa                                              
  7. Strategic Analysis
    1. PESTLE analysis                                         
      1. Political                     
      2. Economic                 
      3. Social                         
      4. Technological                         
      5. Legal                          
      6. Environmental                       
    2. Porter’s Five analysis                                              
      1. Bargaining Power of Suppliers                        
      2. Bargaining Power of Consumers                    
      3. Threat of New Entrants                     
      4. Threat of Substitute Products and Services                              
      5. Competitive Rivalry within the Industry                     
  8. Market Leaders' Analysis
    1. Illumina, Inc. (US)
      1. Overview                 
      2. Product Analysis                   
      3. Strategic Evaluation and Operations                            
      4. Financial analysis                  
      5. Legal issues                             
      6. Recent Developments                       
      7. SWOT analysis                       
      8. Analyst View                          
    2. QIAGEN N.V. (Germany)
    3. NeoGenomics Laboratories, Inc. (US)
    4. HTG Molecular Diagnostics, Inc. (US)
    5. Genomic Health Inc. (US)
    6. Caris Life Sciences (US)
    7. Helomics Corporation (US)
    8. NanoString Technologies, Inc. (US)
    9. Sysmex Corporation (Japan)
    10. RiboMed Biotechnologies, Inc. (US)
    11. Guardant Health, Inc. (US)
    12. Foundation Medicine (US)
  9. Competitive Landscape
    1. Market share analysis                                            
    2. Merger and Acquisition Analysis                                       
    3. Agreements, collaborations and Joint Ventures                                         
    4. New Product Launches                                         
  10. Expert Opinions
    1. Market Outlook                                     
    2. Investment Opportunities                                 
  11. Appendix                                                           
  12. List of Tables
  13. List of Figures
  1. Global Cancer profiling Market, By Region, From 2022 - 2027 (USD Billion)
  2. Global Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  3. Global Next-generation Sequencing (NGS) Market, By Region, From 2022 - 2027 (USD Billion)
  4. Global Polymerase Chain Reaction (PCR) Market, By Region, From 2022 - 2027 (USD Billion)
  5. Global Immunohistochemistry (IHC) Market, By Region, From 2022 - 2027 (USD Billion)
  6. Global In Situ Hybridization (ISH) Market, By Region, From 2022 - 2027 (USD Billion)
  7. Global Microarray Market, By Region, From 2022 - 2027 (USD Billion)
  8. Global Others Market, By Region, From 2022 - 2027 (USD Billion)
  9. Global Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  10. Global GenomicsProteomics Market, By Region, From 2022 - 2027 (USD Billion)
  11. Global Epigenetics Market, By Region, From 2022 - 2027 (USD Billion)
  12. Global Metabolomics Market, By Region, From 2022 - 2027 (USD Billion)
  13. Global Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  14. Global Personalized Medicine Market, By Region, From 2022 - 2027 (USD Billion)
  15. Global Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  16. Global Biomarker Discovery Market, By Region, From 2022 - 2027 (USD Billion)
  17. Global Prognostics Market, By Region, From 2022 - 2027 (USD Billion)
  18. Global Research Applications Market, By Region, From 2022 - 2027 (USD Billion)
  19. Global Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  20. Global Fluorescence In Situ Hybridization (FISH) Market, By Region, From 2022 - 2027 (USD Billion)
  21. Global Chromogenic In Situ Hybridization (CISH) Market, By Region, From 2022 - 2027 (USD Billion)
  22. North America Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  23. North America Next-generation Sequencing (NGS) Market, By Region, From 2022 - 2027 (USD Billion)
  24. North America Polymerase Chain Reaction (PCR) Market, By Region, From 2022 - 2027 (USD Billion)
  25. North America Immunohistochemistry (IHC) Market, By Region, From 2022 - 2027 (USD Billion)
  26. North America In Situ Hybridization (ISH) Market, By Region, From 2022 - 2027 (USD Billion)
  27. North America Microarray Market, By Region, From 2022 - 2027 (USD Billion)
  28. North America Others Market, By Region, From 2022 - 2027 (USD Billion)
  29. North America Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  30. North America GenomicsProteomics Market, By Region, From 2022 - 2027 (USD Billion)
  31. North America Epigenetics Market, By Region, From 2022 - 2027 (USD Billion)
  32. North America Metabolomics Market, By Region, From 2022 - 2027 (USD Billion)
  33. North America Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  34. North America Personalized Medicine Market, By Region, From 2022 - 2027 (USD Billion)
  35. North America Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  36. North America Biomarker Discovery Market, By Region, From 2022 - 2027 (USD Billion)
  37. North America Prognostics Market, By Region, From 2022 - 2027 (USD Billion)
  38. North America Research Applications Market, By Region, From 2022 - 2027 (USD Billion)
  39. United States Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  40. United States Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  41. United States Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  42. Canada Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  43. Canada Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  44. Canada Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  45. North America Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  46. North America Fluorescence In Situ Hybridization (FISH) Market, By Region, From 2022 - 2027 (USD Billion)
  47. North America Chromogenic In Situ Hybridization (CISH) Market, By Region, From 2022 - 2027 (USD Billion)
  48. United States Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  49. Canada Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  50. Europe Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  51. Europe Next-generation Sequencing (NGS) Market, By Region, From 2022 - 2027 (USD Billion)
  52. Europe Polymerase Chain Reaction (PCR) Market, By Region, From 2022 - 2027 (USD Billion)
  53. Europe Immunohistochemistry (IHC) Market, By Region, From 2022 - 2027 (USD Billion)
  54. Europe In Situ Hybridization (ISH) Market, By Region, From 2022 - 2027 (USD Billion)
  55. Europe Microarray Market, By Region, From 2022 - 2027 (USD Billion)
  56. Europe Others Market, By Region, From 2022 - 2027 (USD Billion)
  57. Europe Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  58. Europe GenomicsProteomics Market, By Region, From 2022 - 2027 (USD Billion)
  59. Europe Epigenetics Market, By Region, From 2022 - 2027 (USD Billion)
  60. Europe Metabolomics Market, By Region, From 2022 - 2027 (USD Billion)
  61. Europe Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  62. Europe Personalized Medicine Market, By Region, From 2022 - 2027 (USD Billion)
  63. Europe Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  64. Europe Biomarker Discovery Market, By Region, From 2022 - 2027 (USD Billion)
  65. Europe Prognostics Market, By Region, From 2022 - 2027 (USD Billion)
  66. Europe Research Applications Market, By Region, From 2022 - 2027 (USD Billion)
  67. U.K. Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  68. U.K. Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  69. U.K. Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  70. Germany Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  71. Germany Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  72. Germany Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  73. France Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  74. France Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  75. France Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  76. Italy Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  77. Italy Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  78. Italy Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  79. Spain Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  80. Spain Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  81. Spain Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  82. Europe Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  83. Europe Fluorescence In Situ Hybridization (FISH) Market, By Region, From 2022 - 2027 (USD Billion)
  84. Europe Chromogenic In Situ Hybridization (CISH) Market, By Region, From 2022 - 2027 (USD Billion)
  85. U.K. Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  86. Germany Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  87. France Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  88. Italy Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  89. Spain Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  90. Asia Pacific Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  91. Asia Pacific Next-generation Sequencing (NGS) Market, By Region, From 2022 - 2027 (USD Billion)
  92. Asia Pacific Polymerase Chain Reaction (PCR) Market, By Region, From 2022 - 2027 (USD Billion)
  93. Asia Pacific Immunohistochemistry (IHC) Market, By Region, From 2022 - 2027 (USD Billion)
  94. Asia Pacific In Situ Hybridization (ISH) Market, By Region, From 2022 - 2027 (USD Billion)
  95. Asia Pacific Microarray Market, By Region, From 2022 - 2027 (USD Billion)
  96. Asia Pacific Others Market, By Region, From 2022 - 2027 (USD Billion)
  97. Asia Pacific Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  98. Asia Pacific GenomicsProteomics Market, By Region, From 2022 - 2027 (USD Billion)
  99. Asia Pacific Epigenetics Market, By Region, From 2022 - 2027 (USD Billion)
  100. Asia Pacific Metabolomics Market, By Region, From 2022 - 2027 (USD Billion)
  101. Asia Pacific Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  102. Asia Pacific Personalized Medicine Market, By Region, From 2022 - 2027 (USD Billion)
  103. Asia Pacific Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  104. Asia Pacific Biomarker Discovery Market, By Region, From 2022 - 2027 (USD Billion)
  105. Asia Pacific Prognostics Market, By Region, From 2022 - 2027 (USD Billion)
  106. Asia Pacific Research Applications Market, By Region, From 2022 - 2027 (USD Billion)
  107. Japan Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  108. Japan Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  109. Japan Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  110. China Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  111. China Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  112. China Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  113. India Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  114. India Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  115. India Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  116. Australia Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  117. Australia Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  118. Australia Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  119. South Korea Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  120. South Korea Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  121. South Korea Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  122. Asia Pacific Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  123. Asia Pacific Fluorescence In Situ Hybridization (FISH) Market, By Region, From 2022 - 2027 (USD Billion)
  124. Asia Pacific Chromogenic In Situ Hybridization (CISH) Market, By Region, From 2022 - 2027 (USD Billion)
  125. Japan Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  126. China Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  127. India Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  128. Australia Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  129. Latin America Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  130. Latin America Next-generation Sequencing (NGS) Market, By Region, From 2022 - 2027 (USD Billion)
  131. Latin America Polymerase Chain Reaction (PCR) Market, By Region, From 2022 - 2027 (USD Billion)
  132. Latin America Immunohistochemistry (IHC) Market, By Region, From 2022 - 2027 (USD Billion)
  133. Latin America In Situ Hybridization (ISH) Market, By Region, From 2022 - 2027 (USD Billion)
  134. Latin America Microarray Market, By Region, From 2022 - 2027 (USD Billion)
  135. Latin America Others Market, By Region, From 2022 - 2027 (USD Billion)
  136. Latin America Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  137. Latin America GenomicsProteomics Market, By Region, From 2022 - 2027 (USD Billion)
  138. Latin America Epigenetics Market, By Region, From 2022 - 2027 (USD Billion)
  139. Latin America Metabolomics Market, By Region, From 2022 - 2027 (USD Billion)
  140. Latin America Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  141. Latin America Personalized Medicine Market, By Region, From 2022 - 2027 (USD Billion)
  142. Latin America Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  143. Latin America Biomarker Discovery Market, By Region, From 2022 - 2027 (USD Billion)
  144. Latin America Prognostics Market, By Region, From 2022 - 2027 (USD Billion)
  145. Latin America Research Applications Market, By Region, From 2022 - 2027 (USD Billion)
  146. Brazil Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  147. Brazil Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  148. Brazil Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  149. Argentina Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  150. Argentina Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  151. Argentina Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  152. Mexico Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  153. Mexico Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  154. Mexico Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  155. Rest of Latin America Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  156. Rest of Latin America Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  157. Rest of Latin America Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  158. Latin America Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  159. Latin America Fluorescence In Situ Hybridization (FISH) Market, By Region, From 2022 - 2027 (USD Billion)
  160. Latin America Chromogenic In Situ Hybridization (CISH) Market, By Region, From 2022 - 2027 (USD Billion)
  161. Brazil Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  162. Argentina Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  163. Mexico Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  164. Middle East and Africa Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  165. Middle East and Africa Next-generation Sequencing (NGS) Market, By Region, From 2022 - 2027 (USD Billion)
  166. Middle East and Africa Polymerase Chain Reaction (PCR) Market, By Region, From 2022 - 2027 (USD Billion)
  167. Middle East and Africa Immunohistochemistry (IHC) Market, By Region, From 2022 - 2027 (USD Billion)
  168. Middle East and Africa In Situ Hybridization (ISH) Market, By Region, From 2022 - 2027 (USD Billion)
  169. Middle East and Africa Microarray Market, By Region, From 2022 - 2027 (USD Billion)
  170. Middle East and Africa Others Market, By Region, From 2022 - 2027 (USD Billion)
  171. Middle East and Africa Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  172. Middle East and Africa GenomicsProteomics Market, By Region, From 2022 - 2027 (USD Billion)
  173. Middle East and Africa Epigenetics Market, By Region, From 2022 - 2027 (USD Billion)
  174. Middle East and Africa Metabolomics Market, By Region, From 2022 - 2027 (USD Billion)
  175. Middle East and Africa Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  176. Middle East and Africa Personalized Medicine Market, By Region, From 2022 - 2027 (USD Billion)
  177. Middle East and Africa Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  178. Middle East and Africa Biomarker Discovery Market, By Region, From 2022 - 2027 (USD Billion)
  179. Middle East and Africa Prognostics Market, By Region, From 2022 - 2027 (USD Billion)
  180. Middle East and Africa Research Applications Market, By Region, From 2022 - 2027 (USD Billion)
  181. Middle East Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  182. Middle East Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  183. Middle East Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  184. Africa Cancer profiling Market, By Technology, From 2022 - 2027 (USD Billion)
  185. Africa Cancer profiling Market, By Technique, From 2022 - 2027 (USD Billion)
  186. Africa Cancer profiling Market, By Application, From 2022 - 2027 (USD Billion)
  187. Middle East and Africa Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  188. Middle East and Africa Fluorescence In Situ Hybridization (FISH) Market, By Region, From 2022 - 2027 (USD Billion)
  189. Middle East and Africa Chromogenic In Situ Hybridization (CISH) Market, By Region, From 2022 - 2027 (USD Billion)
  190. Middle East Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)
  191. Africa Cancer Profiling Market, By In Situ Hybridization (ISH), From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

FAQ's

How much was the global cancer profiling market worth in 2021?

The global cancer profiling market size was valued at USD 8.87 billion in 2021.

Which segment by technology accounted for the major share of the cancer profiling market?

Based on technology, the NGS segment led the cancer profiling market in 2021.

Which region led the cancer profiling market in 2021?

Among all the regions, the North American region accounted for the major share of the global market in 2021.

Who are the major players in the cancer profiling market?

Illumina, Inc. (US), QIAGEN N.V. (Germany), NeoGenomics Laboratories, Inc. (U.S.), HTG Molecular Diagnostics, Inc. (U.S.), Genomic Health Inc. (U.S.), Caris Life Sciences (U.S.), Helomics Corporation (U.S.), NanoString Technologies, Inc. (U.S.), Sysmex Corporation (Japan), RiboMed Biotechnologies, Inc. (U.S.), Guardant Health, Inc. (U.S.), and Foundation Medicine (U.S.) are some of the prominent companies in the global cancer profiling market.

Related Reports

PURCHASE OPTIONS

pdf
$

4255


pdf excel
$

5060


pdf excel powerbi
$

7455


excel
$

2500

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 4255

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample